Viewing Study NCT02843061


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-01-02 @ 12:57 PM
Study NCT ID: NCT02843061
Status: COMPLETED
Last Update Posted: 2019-09-12
First Post: 2016-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Rituximab and NK Immunotherapy for B Lymphoma
Sponsor: Fuda Cancer Hospital, Guangzhou
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module